List of Genetic Analysis/Screening Companies in Virginia - 3

GENETWORx Laboratories was formed with the central focus of impacting the lives of our people by empowering their physicians with information. Now, GENETWORx is dedicating our focus to fighting back against COVID-19. GENETWORx' COVID-19 test is the gold standard due to being 10% accurate, with 10% sensitivity and specificity. GENETWORx's COVID-19 test detects infection in the earliest stage, with a long turnaround time. Once a sample has been received in our laboratory, the prescribing physician will have the result via GENETWORx's portal within 10 business days. GENETWORx provides ongoing COVID-19 testing so that states, employers and organizations can continue or again open their operations with a safe and healthy workforce. We are completing thousands upon thousands of tests a day, and are growing to ensure that everyone in the USA can be tested and return to work. GENETWORx has met the Federal and State licensure requirements to operate in all 50 states. • CAP Number: 8732425 • CLIA Number: 49D2060159 Learn more about COVID-19 Testing: https://www.genetworx.com/faqs Our core values: • Personalized patient-centric care • Translating science into actionable intelligence • Supporting doctors and pharmacists in their delivery of top-quality Personalized Medicine • Enabling cost-effective health care • Preserving patient privacy

G3 leverages molecular profiles of human health and disease to develop life changing diagnostics and therapeutics.

NEXT Bio-Research, Services continues a 23 year history in providing comprehensive integrated project support to investigators in the biotech and pharmaceutical sectors. We also provide medical testing services to physicians using state-of-the-art platforms. NEXT Bio-Research Services was founded by three long standing colleagues who have worked together these past 23 years and collectively represent more than 100 years’ experience in life science technologies. NEXT Bio-Research Services is focused in (1) clinical testing using molecular and biochemical techniques; (2) molecular genetics of pharmacogenomics and cancer; (3) contract research in drug discovery and development with private sector customers; and (4) laboratory support of human clinical trials. We function as an extension of your own laboratory in helping you to bring their products from discovery to market. Our laboratories are certified under the Clinical Laboratory Improvement Amendments (CLIA) act and our contract research services are offered individually or can be integrated to support product development from discovery to market with full regulatory support under FDA GLP Guidelines 21 CFR 58.